130 related articles for article (PubMed ID: 10567058)
1. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women.
MacDougall J; Davies MC; Overton CE; Gulekli B; Hall M; Bounds W; Jacobs HS; Guillebaud JG
Br J Fam Plann; 1999 Oct; 25(3):96-100. PubMed ID: 10567058
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
[TBL] [Abstract][Full Text] [Related]
3. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives for the prevention of osteoporosis.
Corson SL
J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
8. The contraceptive and hormonal requirements of the premenopausal woman: the years from forty to fifty.
Upton GV
Int J Fertil; 1986; 30(4):44-52. PubMed ID: 2890595
[TBL] [Abstract][Full Text] [Related]
9. [The effect of oral contraceptives on bone density in climacteric females].
Enzelsberger H; Metka M; Heytmanek G; Huber J
Zentralbl Gynakol; 1989; 111(14):967-73. PubMed ID: 2508368
[TBL] [Abstract][Full Text] [Related]
10. Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls.
Lattakova M; Borovsky M; Payer J; Killinger Z
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):207-14. PubMed ID: 19565418
[TBL] [Abstract][Full Text] [Related]
11. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
12. [Decreased bone mineral density in premenopausal women with amenorrhea].
Kinoshita T; Yasumizu T; Kato J
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):793-8. PubMed ID: 8841045
[TBL] [Abstract][Full Text] [Related]
13. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
[TBL] [Abstract][Full Text] [Related]
14. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in premenopausal women with oestrogen deficiency and symptomatic coronary heart disease.
Bruck B; Seitz D; Hanke S; Lange K; Schmah W; Haasis R; Hanke H
Br J Clin Pract; 1996 Dec; 50(8):450-3. PubMed ID: 9039717
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study.
Shargil AA
Int J Fertil; 1985; 30(1):15, 18-28. PubMed ID: 2862116
[TBL] [Abstract][Full Text] [Related]
17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.
Kleerekoper M; Brienza RS; Schultz LR; Johnson CC
Arch Intern Med; 1991 Oct; 151(10):1971-6. PubMed ID: 1929685
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial.
Ackerman KE; Singhal V; Baskaran C; Slattery M; Campoverde Reyes KJ; Toth A; Eddy KT; Bouxsein ML; Lee H; Klibanski A; Misra M
Br J Sports Med; 2019 Feb; 53(4):229-236. PubMed ID: 30301734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
